Enzon Pharmaceuticals, Inc. (ENZN) Swings to Q1 Loss
Tweet
Share
E-mailGet Alerts ENZN Hot Sheet
Price: $4.35 --0%
Financial Fact:
Net (loss) income: -4.61M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Net (loss) income: -4.61M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) reported Q1 EPS of ($0.02), versus $0.01 reported last year. Revenue for the quarter came in at $10.6 million, versus $18.02 million reported last year.
For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.
For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
- Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
